These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36475432)

  • 1. Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus,
    Kim J; Ko H; Hur JS; An S; Lee JW; Deyrup ST; Noh M; Shim SH
    J Nat Prod; 2022 Dec; 85(12):2804-2816. PubMed ID: 36475432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Naphthol Tetramers from Endolichenic Fungus
    Kim J; He MT; Hur JS; Lee JW; Kang KB; Kang KS; Shim SH
    J Nat Prod; 2023 Aug; 86(8):2031-2038. PubMed ID: 37589086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Phenyl-8-(1-phenylallyl)-chromenone compounds have a pan-PPAR modulator pharmacophore.
    Ahn S; Kim J; An S; Pyo JJ; Jung D; Lee J; Hwang SY; Gong J; Shin I; Kim HP; Kim H; Noh M
    Bioorg Med Chem; 2019 Jul; 27(13):2948-2958. PubMed ID: 31128991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel linked butanolide dimer compounds increase adiponectin production during adipogenesis in human mesenchymal stem cells through peroxisome proliferator-activated receptor γ modulation.
    Ahn S; Basavana Gowda MK; Lee M; Masagalli JN; Mailar K; Choi WJ; Noh M
    Eur J Med Chem; 2020 Feb; 187():111969. PubMed ID: 31865018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator.
    Ko H; An S; Jang H; Ahn S; Park IG; Hwang SY; Gong J; Oh S; Kwak SY; Choi WJ; Kim H; Noh M
    Biomol Ther (Seoul); 2023 May; 31(3):312-318. PubMed ID: 36382477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galangin 3-benzyl-5-methylether derivatives function as an adiponectin synthesis-promoting peroxisome proliferator-activated receptor γ partial agonist.
    Ko H; Jang H; An S; Park IG; Ahn S; Gong J; Hwang SY; Oh S; Kwak SY; Choi WJ; Kim H; Noh M
    Bioorg Med Chem; 2022 Jan; 54():116564. PubMed ID: 34922307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of PPARγ and glucocorticoid receptor dual agonists to promote the adiponectin and leptin biosynthesis in human bone marrow mesenchymal stem cells.
    Ahn S; Ahn M; Park S; An S; Park IG; Hwang SY; Gong J; Oh S; Jin SH; Kim HJ; Cheong JH; Byun Y; Noh M
    Eur J Med Chem; 2023 Jan; 245(Pt 1):114927. PubMed ID: 36379105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Structure-Activity Relationships of Novel Template, Truncated 1'-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators.
    An S; Kim G; Kim HJ; Ahn S; Kim HY; Ko H; Hyun YE; Nguyen M; Jeong J; Liu Z; Han J; Choi H; Yu J; Kim JW; Lee HW; Jacobson KA; Cho WJ; Kim YM; Kang KW; Noh M; Jeong LS
    J Med Chem; 2020 Dec; 63(24):16012-16027. PubMed ID: 33325691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Formyl-komarovicine promotes adiponectin production in human mesenchymal stem cells through PPARγ partial agonism.
    Ahn S; Lee M; An S; Hyun S; Hwang J; Lee J; Noh M
    Bioorg Med Chem; 2018 Mar; 26(5):1069-1075. PubMed ID: 29398443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kojyl cinnamate esters are peroxisome proliferator-activated receptor α/γ dual agonists.
    Kim SO; Han Y; Ahn S; An S; Shin JC; Choi H; Kim HJ; Park NH; Kim YJ; Jin SH; Rho HS; Noh M
    Bioorg Med Chem; 2018 Nov; 26(21):5654-5663. PubMed ID: 30352713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
    PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
    Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H
    Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors alpha and delta and retinoid X receptor alpha involved in the regulation of energy homeostasis, obesity, and inflammation.
    Suhara W; Koide H; Okuzawa T; Hayashi D; Hashimoto T; Kojo H
    J Dairy Sci; 2009 Sep; 92(9):4180-7. PubMed ID: 19700678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4,5-Trimethoxycinnamate thymol ester inhibits melanogenesis in normal human melanocytes and 3D human epidermal equivalents via the PGC-1α-independent PPARγ partial agonism.
    Ko H; Choi H; Han Y; An S; Min D; Park WS; Jin SH; Kim HJ; Noh M
    J Dermatol Sci; 2022 Apr; 106(1):12-20. PubMed ID: 35260321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate.
    Honda A; Kamata S; Akahane M; Machida Y; Uchii K; Shiiyama Y; Habu Y; Miyawaki S; Kaneko C; Oyama T; Ishii I
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.
    Artis DR; Lin JJ; Zhang C; Wang W; Mehra U; Perreault M; Erbe D; Krupka HI; England BP; Arnold J; Plotnikov AN; Marimuthu A; Nguyen H; Will S; Signaevsky M; Kral J; Cantwell J; Settachatgull C; Yan DS; Fong D; Oh A; Shi S; Womack P; Powell B; Habets G; West BL; Zhang KY; Milburn MV; Vlasuk GP; Hirth KP; Nolop K; Bollag G; Ibrahim PN; Tobin JF
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):262-7. PubMed ID: 19116277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzophenone-3 and benzophenone-8 exhibit obesogenic activity via peroxisome proliferator-activated receptor γ pathway.
    Shin JC; Lee E; An S; Jin SH; Ha J; Choi WJ; Noh M
    Toxicol In Vitro; 2020 Sep; 67():104886. PubMed ID: 32407875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
    Hummasti S; Tontonoz P
    Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.